Savant Capital LLC Reduces Holdings in GE HealthCare Technologies Inc. $GEHC

Savant Capital LLC lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 66.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,280 shares of the company’s stock after selling 18,499 shares during the period. Savant Capital LLC’s holdings in GE HealthCare Technologies were worth $687,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Lineweaver Wealth Advisors LLC purchased a new position in GE HealthCare Technologies during the second quarter worth approximately $592,000. Exome Asset Management LLC purchased a new stake in GE HealthCare Technologies during the 1st quarter worth about $2,050,000. Andra AP fonden lifted its position in shares of GE HealthCare Technologies by 104.9% during the 2nd quarter. Andra AP fonden now owns 59,000 shares of the company’s stock worth $4,370,000 after purchasing an additional 30,200 shares during the last quarter. Bridge Creek Capital Management LLC increased its stake in GE HealthCare Technologies by 58.2% in the second quarter. Bridge Creek Capital Management LLC now owns 31,852 shares of the company’s stock valued at $2,359,000 after purchasing an additional 11,719 shares during the last quarter. Finally, Atlantic Union Bankshares Corp purchased a new position in shares of GE HealthCare Technologies during the second quarter worth approximately $89,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently issued reports on GEHC shares. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the stock from $93.00 to $83.00 in a research note on Tuesday, October 7th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Wells Fargo & Company cut their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Finally, Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $86.10.

GE HealthCare Technologies Trading Down 1.1%

GEHC stock opened at $73.15 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The business has a fifty day moving average of $75.15 and a 200-day moving average of $73.68. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The company has a market cap of $33.32 billion, a P/E ratio of 15.11, a PEG ratio of 2.78 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.